Information from Industry-Sponsored Content
Primary Biliary Cholangitis: Managing a Progressive Liver Disease
Developed under the direction and sponsorship of Ipsen Biopharmaceuticals
March 19, 2024|GI and Hepatology News
Primary biliary cholangitis is a rare progressive autoimmune liver disease that specifically targets biliary epithelial cells. In this article, Dr. Kowdley describes prognostic markers of disease, current and investigational medical therapies, liver transplant, and focusing on maximizing favorable long-term outcomes.
,